Steve Damment
Oprichter bij Aluztura Bio Ltd.
Actieve functies van Steve Damment
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Aluztura Bio Ltd. | Oprichter | 01-01-2014 | - |
Corporate Officer/Principal | 01-01-2014 | - |
Loopbaan van Steve Damment
Eerdere bekende functies van Steve Damment
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BIODEXA PHARMACEUTICALS PLC | Hoofd Techniek/Wetenschap/O&O | 01-06-2018 | 30-09-2021 |
Corporate Officer/Principal | 01-05-2015 | 01-06-2018 | |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Corporate Officer/Principal | 01-01-2000 | 01-12-2013 |
GSK PLC | Corporate Officer/Principal | 01-07-1982 | 01-12-1999 |
Opleiding van Steve Damment
The University of Liverpool | Undergraduate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 6 |
Operationeel
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoraal
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
GSK PLC | Health Technology |
BIODEXA PHARMACEUTICALS PLC | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
Aluztura Bio Ltd. |
- Beurs
- Insiders
- Steve Damment
- Ervaring